However, evidence on longer-term outcomes, side effects, and potential conflicts of interest remains limited or uncertain
Engineered nutrient-stimulated hormonal multi-agonists for precision targeting of obesity and metabolic disorders
Sample size was determined based on practical considerations, prior experience with similar phase 1 study designs, and the objective of obtaining sufficient safety and pharmacokinetic data to support dose escalation decisions
A 3-month open-label trial investigated the weight loss and glycemic control effects of benaglutide in patients with T2DM
Tirzepatide is the active molecule sold as Zepbound for weight loss and Mounjaro for type 2 diabetes the rashes and injection-site reactions described here apply to all three brand names
Until they are, this page states only what was measured and in whom